The introduction of available in vitro diagnostic (IVD) PCR assays into the clinical microbiology laboratory has facilitated enhancements to patient care, improving diagnostic sensitivity and specificity.

The global Infectious Disease Testing Using PCR for IVD market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Infectious Disease Testing Using PCR for IVD volume and value at global level, regional level and company level. From a global perspective, this report represents overall Infectious Disease Testing Using PCR for IVD market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Thermo Fisher
BD
Roche Diagnostics
Merck
Siemens Healthineers
Hologic
Abbott Laboratories
BioMerieux
Cepheid
Bayer
Sysmex
Ortho Clinical Diagnostics
Qiagen
Codexis
Bio-Rad Laboratories
Oxford Nanopore

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Direct Detection
Indirect Detection

Segment by Application
Hospitals
Laboratory
Other